Viral persistence, reactivation, and mechanisms of long COVID
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals. Following COVID-19 infection, a subset can develop a wide range of chronic symptoms affecting diverse organ systems referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. A National Institutes of Health-sponsored initiative, RECOVER: Researching COVID to Enhance Recovery, has sought to understand the basis of long COVID in a large cohort. Given the range of symptoms that occur in long COVID, the mechanisms that may underlie these diverse symptoms may also be diverse. In this review, we focus on the emerging literature supporting the role(s) that viral persistence or reactivation of viruses may play in PASC. Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear. Understanding the mechanisms of persistence of RNA, antigen or other reactivated viruses and how they may relate to specific inflammatory responses that drive symptoms of PASC may provide a rationale for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981 · cited 2×
“ADE has been reported with several viral infections including dengue virus (DENV) and respiratory syncytial virus (RSV) (Dejnirattisai et al., 2010; Kim et al., 1969).”
BackgroundMultiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114583 · Cited by 1,703
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J., & Ho, A. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30172-5 · Cited by 1,350
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J. P., Schröder, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30308-2 · Cited by 1,300
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217 · cited 1×
“Similarly, myocarditis or related cardiac inflammatory issues identified in some individuals with PASC after acute COVID- 19 may be driven directly by SARS- CoV2 but herpesviruses including HHV- 6 have been described as the causes for virusassociated inflammatory cardiomyopathy (Tschöpe et al., 2021).”
BackgroundMultiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Perrett, H. R., Painter, C. D., Narayanan, A., Majowicz, S. A., Kwong, E. M., McVicar, R. N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.033 · Cited by 1,136
Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples
Bullard, J., Dust, K., Funk, D., Strong, J. E., Alexander, D., Garnett, L., Boodman, C., Bello, A., Hedley, A., Schiffman, Z., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa638 · Cited by 1,075 · cited 1×
“86015 4 of 15 (Bullard et al., 2020; Liu et al., 2020; Wölfel et al., 2020), except in those with significant immune”
BackgroundNeuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2025179 · Cited by 1,021
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.044 · Cited by 905 · cited 1×
“Diverse cell types within different organ systems express receptors that may make these cells directly vulnerable to infection by SARS- CoV2, including alveolar macrophages; renal tubular cells; gastrointestinal epithelia in the ileum, colon, and rectum; esophageal keratinocytes; and liver cholangiocytes (Delorey et a…”
BackgroundPreexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 876
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.053 · Cited by 865
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Delorey, T. M., Ziegler, C. G. K., Heimberg, G., Normand, R., Yang, Y., Segerstolpe, Å., Abbondanza, D., Fleming, S. J., Subramanian, A., Montoro, D. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03570-8 · Cited by 794
A molecular single-cell lung atlas of lethal COVID-19
Melms, J. C., Biermann, J., Huang, H., Wang, Y., Nair, A., Tagore, S., Katsyv, I., Rendeiro, A. F., Amin, A. D., Schapiro, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03569-1 · Cited by 679
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Lee, W. S., Wheatley, A. K., Kent, S. J., & DeKosky, B. J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00789-5 · Cited by 676
Sharova, L. V., Sharov, A. A., Nedorezov, T., Piao, Y., Shaik, N., & Ko, M. S. H. (2009) · DNA Research · doi:10.1093/dnares/dsn030 · Cited by 591 · cited 3×
“to hours rather than months or years, and there are not thought to be major exceptions for specific RNAs (Sharova et al., 2009).”
BackgroundInfluentialCromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Kent, S. J., Triccas, J. A., Khoury, D. S., & Davenport, M. P. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00267-6 · Cited by 590
Swank, Z., Senussi, Y., Manickas-Hill, Z., Yu, X. G., Li, J. Z., Alter, G., & Walt, D. R. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac722 · Cited by 572
de Melo, G. D., Lazarini, F., Levallois, S., Hautefort, C., Michel, V., Larrous, F., Verillaud, B., Aparicio, C., Wagner, S., Gheusi, G., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8396 · Cited by 500
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Dysregulation of type I interferon responses in COVID-19
Acharya, D., Liu, G., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0346-x · Cited by 454 · cited 1×
“Reactivation of latent viruses has been linked to the dysregulation of the host immune response during acute SARS- CoV2 infection, that is, by disabling the host type I interferon response via autoantibodies (Acharya et al., 2020), resulting in decreased control of these latent pathogens.”
BackgroundLevin, L. I. (2005) · JAMA · doi:10.1001/jama.293.20.2496 · Cited by 448
Cohen, K. W., Linderman, S. L., Moodie, Z., Czartoski, J., Lai, L., Mantus, G., Norwood, C., Nyhoff, L. E., Edara, V. V., Floyd, K., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100354 · Cited by 441
Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.010 · Cited by 388
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 371
Recent endemic coronavirus infection is associated with less severe COVID-19
Sagar, M., Reifler, K., Rossi, M., Miller, N. S., Sinha, P., White, L. F., & Mizgerd, J. P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143380 · Cited by 324
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
Zollner, A., Koch, R., Jukic, A., Pfister, A., Meyer, M., Rössler, A., Kimpel, J., Adolph, T. E., & Tilg, H. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.04.037 · Cited by 307
Prolonged virus shedding even after seroconversion in a patient with COVID-19
Liu, W.-D., Chang, S.-Y., Wang, J.-T., Tsai, M.-J., Hung, C.-C., Hsu, C.-L., & Chang, S.-C. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.063 · Cited by 283
Patterson, B. K., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, M., Parikh, P., Guevara-Coto, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746021 · Cited by 280
Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · doi:10.1101/2021.07.29.454333 · Cited by 275
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · Nature · doi:10.1038/s41586-021-04060-7 · Cited by 275
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., Garcia-Valtanen, P., Al-Delfi, Z., Gummow, J., Ferguson, C., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02228-6 · Cited by 274
DeLorenze, G. N., Munger, K. L., Lennette, E. T., Orentreich, N., Vogelman, J. H., & Ascherio, A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.noc50328 · Cited by 257
Peluso, M. J., Deitchman, A. N., Torres, L., Iyer, N. S., Munter, S. E., Nixon, C. C., Donatelli, J., Thanh, C., Takahashi, S., Hakim, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109518 · Cited by 248
Evans, J. P., Zeng, C., Carlin, C., Lozanski, G., Saif, L. J., Oltz, E. M., Gumina, R. J., & Liu, S.-L. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn8057 · Cited by 236
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study
Clark, D. V., Kibuuka, H., Millard, M., Wakabi, S., Lukwago, L., Taylor, A., Eller, M. A., Eller, L. A., Michael, N. L., Honko, A. N., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70152-0 · Cited by 236 · cited 1×
“, 2017), even after the virus has cleared from blood, persisting for months to years and in some cases inducing chronic symptoms or reactivation of live Ebola virus that results in new outbreaks (Clark et al., 2015; Keita et al., 2021; Wilson et al., 2018).”
BackgroundVirus Detection: A Review of the Current and Emerging Molecular and Immunological Methods
Cassedy, A., Parle-McDermott, A., & O’Kennedy, R. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.637559 · Cited by 228
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
Cervia, C., Zurbuchen, Y., Taeschler, P., Ballouz, T., Menges, D., Hasler, S., Adamo, S., Raeber, M. E., Bächli, E., Rudiger, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27797-1 · Cited by 226
Immunological imprinting of the antibody response in COVID-19 patients
Aydillo, T., Rombauts, A., Stadlbauer, D., Aslam, S., Abelenda-Alonso, G., Escalera, A., Amanat, F., Jiang, K., Krammer, F., Carratala, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23977-1 · Cited by 223
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks
Keita, A. K., Koundouno, F. R., Faye, M., Düx, A., Hinzmann, J., Diallo, H., Ayouba, A., Le Marcis, F., Soropogui, B., Ifono, K., et al. (2021) · Nature · doi:10.1038/s41586-021-03901-9 · Cited by 215 · cited 1×
“, 2017), even after the virus has cleared from blood, persisting for months to years and in some cases inducing chronic symptoms or reactivation of live Ebola virus that results in new outbreaks (Clark et al., 2015; Keita et al., 2021; Wilson et al., 2018).”
BackgroundAnand, S. P., Prévost, J., Nayrac, M., Beaudoin-Bussières, G., Benlarbi, M., Gasser, R., Brassard, N., Laumaea, A., Gong, S. Y., Bourassa, C., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100290 · Cited by 175 · cited 1×
“In SARSCoV2 infection, neutralizing antibody responses wane rapidly, although binding antibodies persist (Anand et al., 2021).”
Positive Epstein-Barr Virus Detection in Corona Virus Disease 2019 (COVID-19) Patients
Chen, T., Song, J., Liu, H., Zheng, H., & Chen, C. (2020) · Scientific Reports · doi:10.1038/s41598-021-90351-y · Cited by 174
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Files, J. K., Boppana, S., Perez, M. D., Sarkar, S., Lowman, K. E., Qin, K., Sterrett, S., Carlin, E., Bansal, A., Sabbaj, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140491 · Cited by 168
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.023 · Cited by 163
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Yamayoshi, S., Yasuhara, A., Ito, M., Akasaka, O., Nakamura, M., Nakachi, I., Koga, M., Mitamura, K., Yagi, K., Maeda, K., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100734 · Cited by 159
T Cell Memory: Understanding COVID-19
Jarjour, N. N., Masopust, D., & Jameson, S. C. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.009 · Cited by 158
Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 156
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
Rebman, A. W., & Aucott, J. N. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00057 · Cited by 155
Craddock, V. D., Mahajan, A., Spikes, L. A., Krishnamachary, B., Ram, A. K., Kumar, A., Chen, L., Chalise, P., & Dhillon, N. K. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28568 · Cited by 152 · cited 1×
“been associated with PASC in a small group of postacute COVID patients (Craddock et al., 2023; Craddock et al., 2022).”
BackgroundSARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
Vibholm, L. K., Nielsen, S. S. F., Pahus, M. H., Frattari, G. S., Olesen, R., Andersen, R., Monrad, I., Andersen, A. H. F., Thomsen, M. M., Konrad, C. V., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103230 · Cited by 149
Zaid, A., Gérardin, P., Taylor, A., Mostafavi, H., Malvy, D. J.-M., & Mahalingam, S. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40403 · Cited by 138 · cited 1×
“86015 2 of 15 development of chronic symptoms in a subset of infected individuals (Bannister, 1988; Keita et al., 2019; Komaroff, 2006; Rebman and Aucott, 2020; Wilson et al., 2018; Zaid et al., 2018).”
BackgroundTejerina, F., Catalan, P., Rodriguez-Grande, C., Adan, J., Rodriguez-Gonzalez, C., Muñoz, P., Aldamiz, T., Diez, C., Perez, L., Fanciulli, C., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07153-4 · Cited by 131
Littlefield, K. M., Watson, R. O., Schneider, J. M., Neff, C. P., Yamada, E., Zhang, M., Campbell, T., Falta, M. T., Jolley, S. E., Fontenot, A. P., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010359 · Cited by 125
Involvement of CD8+ T Cells in Multiple Sclerosis
Salou, M., Nicol, B., Garcia, A., & Laplaud, D.-A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00604 · Cited by 122 · cited 1×
“, 2005) and specifically highlighting (EBV- specific) CD8+ T cells as these cells play a key role in antiviral immunity and dominate the CNS immune infiltrate in MS (Salou et al., 2015; van Nierop et al., 2016).”
BackgroundHuman herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19
Drago, F., Ciccarese, G., Rebora, A., & Parodi, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26549 · Cited by 115
Stress-Induced Epstein-Barr Virus Reactivation
Sausen, D. G., Bhutta, M., Gallo, E. S., Dahari, H., & Borenstein, R. (2021) · Biomolecules · doi:10.3390/biom11091380 · Cited by 113
Author Correction: Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2984-3 · Cited by 109
Xu, R., Zhou, Y., Cai, L., Wang, L., Han, J.-B., Yang, X., Chen, J., Chen, J., Ma, C., & Shen, L.-L. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19484 · Cited by 103
Guo, L., Wang, Y., Kang, L., Hu, Y., Wang, L., Zhong, J., Chen, H., Ren, L., Gu, X., Wang, G., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1905488 · Cited by 103
Tissue-specific immunity for a changing world
Weisberg, S. P., Ural, B. B., & Farber, D. L. (2021) · Cell · doi:10.1016/j.cell.2021.01.042 · Cited by 100 · cited 1×
“cytes, however, can generally be divided into circulating memory cells, found in peripheral blood, and tissue- resident memory cells that reside in the non- lymphoid tissues (Jarjour et al., 2021; Weisberg et al., 2021).”
BackgroundIs human herpesvirus-6 a trigger for chronic fatigue syndrome?
Komaroff, A. L. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)70010-5 · Cited by 92 · cited 1×
“DOI: https://doi.org/10.7554/eLife.86015 2 of 15 development of chronic symptoms in a subset of infected individuals (Bannister, 1988; Keita et al., 2019; Komaroff, 2006; Rebman and Aucott, 2020; Wilson et al., 2018; Zaid et al., 2018).”
BackgroundInfluentialPost-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016
Wilson, H. W., Amo-Addae, M. P., Kenu, E., Ilesanmi, O. S., Ameme, D. K., & Sackey, S. O. (2018) · BioMed Research International · doi:10.1155/2018/1909410 · Cited by 89
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Kapłonek, P., Wang, C., Bartsch, Y. C., Fischinger, S., Gorman, M. J., Bowman, K. A., Kang, J., Dayal, D., Martin, P., Nowak, R. P., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj2901 · Cited by 78
Aguilar-Bretones, M., Westerhuis, B. M., Raadsen, M. P., de Bruin, E., Chandler, F. D., Okba, N. M. A., Haagmans, B. L., Langerak, T., Endeman, H., van den Akker, J. P. C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150613 · Cited by 72
Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection*
Chiale, C., Greene, T. T., & Zúñiga, E. I. (2022) · Immunological Reviews · doi:10.1111/imr.13113 · Cited by 71
Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins
van Nierop, G. P., Mautner, J., Mitterreiter, J. G., Hintzen, R. Q., & Verjans, G. M. G. M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515588581 · Cited by 71
Lo, T., Marston, B. J., Dahl, B. A., & Cock, K. M. D. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-052915-015604 · Cited by 61 · cited 1×
“Viral persistence in socalled ‘sanctuary tissues’ has been demonstrated for Ebola virus (Keita et al., 2019; Lo et al., 2017), even after the virus has cleared from blood, persisting for months to years and in some cases inducing chronic symptoms or reactivation of live Ebola virus that results in new outbreaks (Clark…”
BackgroundDeficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients
Duan, Y.-Q., Xia, M.-H., Ren, L., Zhang, Y.-F., Ao, Q.-L., Xu, S.-P., Kuang, D., Liu, Q., Yan, B., Zhou, Y.-W., et al. (2020) · Current Medical Science · doi:10.1007/s11596-020-2225-x · Cited by 59
Kéita, A. K., Vidal, N., Touré, A. F., Diallo, M. S. K., Magassouba, N., Baize, S., Mateo, M., Raoul, H., Mély, S., Subtil, F., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz482 · Cited by 59
Post-infectious disease syndrome
Bannister, B. A. (1988) · Postgraduate Medical Journal · doi:10.1136/pgmj.64.753.559 · Cited by 59 · cited 1×
“DOI: https://doi.org/10.7554/eLife.86015 2 of 15 development of chronic symptoms in a subset of infected individuals (Bannister, 1988; Keita et al., 2019; Komaroff, 2006; Rebman and Aucott, 2020; Wilson et al., 2018; Zaid et al., 2018).”
BackgroundInfluentialDynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals
Luo, L., Liang, W., Pang, J., Xu, G., Chen, Y., Guo, X., Wang, X., Zhao, Y., Lai, Y., Liu, Y., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00321-x · Cited by 58
Tan, P.-H., Ji, J., Hsing, C., Tan, R., & Ji, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214394 · Cited by 57
Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
Temerozo, J. R., Rodrigues, N. F., dos Santos, M. C., Hottz, E. D., Sacramento, C. Q., da Silva, A. D. P. D., Mandacaru, S. C., Moraes, E. C. D. S., Trugilho, M. R. O., Gesto, J. S. M., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01260-9 · Cited by 52
T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVIDPreprint
Visvabharathy, L., Hanson, B. A., Orban, Z. S., Lim, P. H., Palacio, N. M., Jimenez, M., Clark, J. R., Graham, E. L., Liotta, E. M., Tachas, G., et al. (2021) · medRxiv · doi:10.1101/2021.08.08.21261763 · Cited by 43
Simula, E. R., Manca, M. A., Noli, M., Jasemi, S., Ruberto, S., Uzzau, S., Rubino, S., Manca, P. C., & Sechi, L. A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01280-22 · Cited by 40
Pereira, C., Harris, B. H. L., Giovannantonio, M. D., Rosadas, C., Short, C.-E. S., Quinlan, R. A., Sureda-Vives, M., Fernández, N., Day-Weber, I., Khan, M., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab120 · Cited by 37
MicroRNA Regulation of Human Herpesvirus Latency
Chen, S., Deng, Y. C., & Pan, D. (2022) · Viruses · doi:10.3390/v14061215 · Cited by 31
Hao, Z., Wang, G., Mao, D., Zhang, B., Li, H., Zuo, M., Zhao, Z., & Yen, J. (2021) · Foods · doi:10.3390/foods10061398 · Cited by 22 · cited 1×
“Some studies have demonstrated a correlation between EBV reactivation and development of PASC (Hao et al., 2021; Su et al., 2022).”
BackgroundOmololu, A., Ojelade, B., Ajayi, O. C., Adesomi, T., Alade, O., Adebisi, S., & Nwadike, V. U. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x211015494 · Cited by 17
Chen, W., Hu, Z., Yi, C., Chi, Y., Xiong, Q., Tan, C. W., Yi, Y., & Wang, L. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200099 · Cited by 8 · cited 1×
“, 2021), although there is a report of chronic shedding by PCR in a patient without longterm symptoms (Chen et al., 2020).”
Background
Cited by
Greenhalgh, T., Sivan, M., Perlowski, A., & Nikolich, J. Ž. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01136-x · Cited by 502
Greene, C., Connolly, R., Brennan, D., Laffan, A., O’Keeffe, E., Zaporojan, L., O’Callaghan, J., Thomson, B., Connolly, E., Argue, R., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01576-9 · Cited by 429
Metadata
- Authors
- Chen, B., Julg, B., Mohandas, S., Bradfute, S. B., & RECOVER Mechanistic Pathways Task Force
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2023-05-04
- Volume
- 12
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W4368361447
- Cited by
- 190
- References
- 95
- FWCI
- 27.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.